Based on their TH-like activities and efficacy as TTR stabilizers in Aβ-related pathologies, we propose that GC-1, together with its analogs, IS25 and TG68, could be novel candidates as multi-functional drugs for TTR amyloidosis, and related pathologies. This evidence concerns the gene TTR and amyloidosis.